UBS Group

UBS Group’s HCM Acquisition Corp Warrant HCMAW Stock Holding History

UBS Group’s Portfolio HCMAW Stock Details HCMAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-123	Closed	-$2	–	10258
2023 Q3	$2	Buy	+123	New	+$3	﹤0.01%	9364

Other funds holding HCMAW

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

UBS Group's HCMAW Position: Q4 2023 in Review

UBS Group sold out of HCM Acquisition Corp Warrant (HCMAW) in Q4 2023, closing a stake of 123 shares — an estimated $2 sold.

UBS Group first reported a position in HCMAW in Q3 2023 and held it in 1 quarter. The position peaked at $2 in Q3 2023. 41 funds tracked by Wall St. Rank hold HCMAW as of Q4 2023.

UBS Group reported no remaining HCM Acquisition Corp Warrant position as of Q4 2023 after selling out during the quarter.
UBS Group sold 123 HCM Acquisition Corp Warrant shares in Q4 2023, an estimated $2.
UBS Group first reported a position in HCM Acquisition Corp Warrant in Q3 2023 and held it in 1 quarter.
UBS Group's HCM Acquisition Corp Warrant position peaked at $2 in Q3 2023.
41 funds tracked by Wall St. Rank held HCM Acquisition Corp Warrant as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.